Cleared Traditional

OSTEONICS PS HEMI-HIP STEM SERIES (K933882) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
734d
Days
Class 2
Risk

K933882 is an FDA 510(k) clearance for the OSTEONICS PS HEMI-HIP STEM SERIES. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Osteonics Corp. (Allendale, US). The FDA issued a Cleared decision on August 14, 1995 after a review of 734 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Osteonics Corp. devices

Submission Details

510(k) Number K933882 FDA.gov
FDA Decision Cleared Substantially Equivalent - NSE Converted (SN)
Date Received August 10, 1993
Decision Date August 14, 1995
Days to Decision 734 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
612d slower than avg
Panel avg: 122d · This submission: 734d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 324
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K933882.
HOWMEDICA(R) ACETABULAR COMP PACK/MANUF METH CHANGE
K934060 · Howmedica Corp. · Aug 1995
PACKAGING AND MANUFACTURING METHODS CHANGE/KNEE COMPONENTS
K936292 · Howmedica Corp. · Aug 1995
DEPUY DURALOC 400 ACETABULAR CUP
K952740 · Depuy, Inc. · Aug 1995
VITALOCK SOLID BACKED ACETABULAR SHELL
K952397 · Howmedica Corp. · Jul 1995
SYSTEM 12 P1 26MM ACETABULAR INSERT
K951114 · Howmedica Corp. · Jun 1995
HOWMEDICA VITALOCK 22MM ACERTABULAR SHELL AND SYSTEM 12 INSERTS
K951115 · Howmedica Corp. · Jun 1995